Metastatic Breast Cancer

A roundup of the latest news and updates for patients with metastatic breast cancer from CURE®.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for August 2020.

There are women all over the world advocating for flat closure and starting nonprofits to put flat on the menu and make it a viable choice when it comes to mastectomy.

In addition to not delaying disease worsening, the immunotherapy Tecentriq was associated with a negative survival trend, but data on the length of life were immature at the time of analysis and further analysis is planned.

Patients with stage 4 metastatic breast cancer need so much more. All I want is more time, because six years is just not enough.

“This study has highlighted the potential benefit of supportive resources to help women with (metastatic breast cancer) guard against potentially severe cancer-related financial losses for themselves and others within their households,” the authors wrote.

After being diagnosed with metastatic breast cancer, nurse Stephanie Walker was thrown into a world of isolation and new depths of depression she “never knew even existed”. Here, she details how working with a therapist and communicating with her family and friends helped her find her way out of the darkness.

While it may be tempting to “go to that dark place” when feeling the isolation that comes with metastatic breast cancer or a pandemic, Stephanie Walker shares her tips for how to emerge and connect with others.

In both diagnosis and treatment of cancer, there is a growing role for radiation drugs that are injected, ingested or inserted.

Channeling the fear of unwanted change into the hard-fought promise of a transformed life.

In order to combat resistance to certain treatments for patients with metastatic breast cancer, researchers look to a novel combination of pyrotinib plus Xeloda to help increase progression-free survival in patients.

First-line treatment with Keytruda (pembrolizumab) in combination with chemotherapy improves progression-free survival in patients with locally recurrent, inoperable or metastatic triple-negative breast cancer (mTNBC), according to data presented at the 2020 ASCO Virtual Scientific Program.

Traveling with cancer during a pandemic requires some planning. Here's how I did it safely.

Mary Trouba, a patient with metastatic inflammatory breast cancer, talks about the 20 things she has learned on her own cancer journey.

Metastatic breast cancer doesn’t keep Nalie Agustin from raising awareness and empowering others.

“This is the first randomized trial to demonstrate an overall survival benefit for patients with brain metastases, which I think is very significant,” said Dr. Nancy U. Lin.

We are proud of our ANGEL Advocates who are leading through example as we mobilize nationally and globally to #StayHome. Read their blogs to learn more about what they’ve been doing during these uncertain times.

One person with cancer details their challenges with fighting for social security while battling a metastatic breast cancer diagnosis.

It's not just time spent sitting in the lobby. Waiting is a way of life for people with cancer.

Cancer changes us, and often we find new parts of ourselves that help us accomplish new goals in the face of adversity and tragedy.

The Food and Drug Administration’s recent approval of the first antibody-drug conjugate to treat patients with pretreated metastatic triple-negative breast cancer is a major milestone, according to one expert.

The Food and Drug Administration approved the targeted therapy Tukysa as part of a drug combination to treat HER2-positive breast cancer. Here’s what you need to know.

Looking at new data from the phase 3 PEARL trial, Dr. Melissa K. Accordino discusses how the use of CDK4/6 inhibitors could help patients with HR-positive/HER2-negative metastatic breast cancer move away from chemotherapy.

Choosing the best path forward is hard under any circumstance, but today, those decisions are wrought with additional unknowable risks.

Survival strategies for her best life help this metastatic cancer patient navigate a new world in the wake of the COVID-19 pandemic.

The Food and Drug Administration approved an updated dose of Ontruzant, a biosimilar to Herceptin, for multiple cancer types.

Understanding a diagnosis is not just something for a patient's care team, the patient needs to understand their diagnosis as well.